← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $295K of Karuna Therapeutics, Inc.

Sold$294,550
$117.82Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Wed, Sep 1. Filed Wed, Sep 1, 4:28 PM ET, after the close. Not investment advice.